Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria.
Franklin BS, Ishizaka ST, Lamphier M, Gusovsky F, Hansen H, Rose J, Zheng W, Ataíde MA, de Oliveira RB, Golenbock DT, et al. Proc Natl Acad Sci U S A. 2011 Mar 1; 108(9):3689-94. Epub 2011 Feb 8.